# US 2006/0067890 A1 · Telomelysin/GFP-expressing recombinant virus

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0067890 A1
- Document ID: US20060067890A1
- Status: Published application
- Kind: A1
- Application number: 11/158,479
- Filed: 2005-06-21
- Published: 2006-03-30
- Earliest claimed: 2004-09-29
- Assignees: Oncolys BioPharma Inc.
- Inventors: Toshiyoshi Fujiwara; Noriaki Tanaka; Satoru Kyo; Hiroyuki Mizuguchi; Takao Hayakawa
- Web page: https://patentgrep.com/patent/US20060067890A1

## CPC

- C12N 15/86: Viral vectors
- A61K 49/0047: {Green fluorescent protein [GFP]}
- A61P 35/00: Antineoplastic agents
- A61P 35/02: specific for leukemia
- A61P 35/04: specific for metastasis
- A61P 37/00: Drugs for immunological or allergic disorders
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07K 14/4702: {Regulators; Modulating activity}
- C07K 14/70575: {NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154 (NGF C07K14/48, TNF C07K14/525)}
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- G01N 33/575: for cancer
- C12N 2710/10343: viral genome or elements thereof as genetic vector
- C12N 2830/008: cell type or tissue specific enhancer/promoter combination
- C12N 2840/203: having an IRES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides a reagent for cancer cell detection or cancer diagnosis. The present invention relates to a reagent for cancer cell detection, comprising a recombinant virus where a replication cassette comprising a promoter from human telomerase, an E1A gene, an IRES sequence and an E1B gene in this order is integrated in E1 region of the viral genome and a labeling cassette comprising a gene encoding a labeling protein and a promoter capable of regulating the expression of the gene encoding the labeling protein is integrated in E3 region of the viral genome.

## Claims

### Claim 1

A reagent for cancer cell detection, comprising a recombinant virus where a replication cassette comprising a promoter from human telomerase, an E1A gene, an IRES sequence and an E1B gene in this order is integrated in E1 region of the viral genome and a labeling cassette comprising a gene encoding a labeling protein and a promoter capable of regulating the expression of the gene encoding the labeling protein is integrated in E3 region of the viral genome.

### Claim 2

A reagent for cancer diagnosis, comprising a recombinant virus where a replication cassette comprising a promoter from human telomerase, an E1A gene, an IRES sequence and an E1B gene in this order is integrated in E1 region of the viral genome and a labeling cassette comprising a gene encoding a labeling protein and a promoter capable of regulating the expression of the gene encoding the labeling protein is integrated in E3 region of the viral genome.

### Claim 3 (depends on 1)

The reagent according to claim 1, wherein the reagent is used for in vivo cancer detection or diagnosis, or for navigation surgery.

### Claim 4 (depends on 1)

The reagent according to claim 1, wherein the promoter from human telomerase is hTERT promoter.

### Claim 5 (depends on 1)

The reagent according to claim 1, wherein the labeling protein is GFP.

### Claim 6 (depends on 1)

The reagent according to claim 1, wherein the promoter capable of regulating the expression of the gene encoding a labeling protein is a cytomegalovirus promoter.

### Claim 7 (depends on 1)

The reagent according to claim 1, wherein the virus is an adenovirus.

### Claim 8

A cell death-inducing agent, comprising a recombinant virus where a replication cassette comprising a promoter from human telomerase, an E1A gene, an IRES sequence and an E1B gene in this order is integrated in E1 region of the viral genome and a cell death-inducing cassette comprising a gene encoding a protein associated with cell death induction and a promoter capable of regulating the expression of the gene encoding the protein is integrated in E3 region of the viral genome.

### Claim 9 (depends on 8)

The cell death-inducing agent according to claim 8, wherein the promoter from human telomerase is hTERT promoter.

### Claim 10 (depends on 8)

The cell death-inducing agent according to claim 8, wherein the protein associated with cell death induction is at least one selected from the group consisting of immunity-associated protein, apoptosis-inducing protein and telomerase-associated protein.

### Claim 11 (depends on 10)

The cell death-inducing agent according to claim 10, wherein the immunity-associated protein is PA28.

### Claim 12 (depends on 10)

The cell death-inducing agent according to claim 10, wherein the apoptosis-inducing protein is TRAIL.

### Claim 13 (depends on 10)

The cell death-inducing agent according to claim 10, wherein the telomerase-associated protein is AU5.

### Claim 14 (depends on 8)

The cell death-inducing agent according to claim 8, wherein the promoter capable of regulating the gene encoding the protein associated with cell death induction is a cytomegalovirus promoter.

### Claim 15 (depends on 8)

The cell death-inducing agent according to claim 8, wherein the virus is an adenovirus.

### Claim 16 (depends on 8)

The cell death-inducing agent according to claim 8, wherein the cell is a cancer cell.

### Claim 17 (depends on 1)

A method of detecting cancer cells, comprising infecting cancer cells with the reagent according to claim 1, and detecting the fluorescence emitted by the cancer cells.

### Claim 18 (depends on 2)

A method of cancer diagnosis, comprising infecting cancer cells with the reagent according to claim 2, and detecting the fluorescence emitted by the cancer cells.

### Claim 19 (depends on 8)

A method of inducing cell death in a target cell, comprising infecting the target cell with the cell death-inducing agent according to claim 8.

### Claim 20 (depends on 2)

The reagent according to claim 2, wherein the reagent is used for in vivo cancer detection or diagnosis, or for navigation surgery.

### Claim 21 (depends on 2)

The reagent according to claim 2, wherein the promoter from human telomerase is hTERT promoter.

### Claim 22 (depends on 2)

The reagent according to claim 2, wherein the labeling protein is GFP.

### Claim 23 (depends on 2)

The reagent according to claim 2, wherein the promoter capable of regulating the expression of the gene encoding a labeling protein is a cytomegalovirus promoter.

### Claim 24 (depends on 2)

The reagent according to claim 2, wherein the virus is an adenovirus.
